{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:51:13Z","timestamp":1761058273870},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1995,1,1]],"date-time":"1995-01-01T00:00:00Z","timestamp":788918400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[1995,1]]},"DOI":"10.1007\/bf01489490","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T12:04:39Z","timestamp":1113480279000},"page":"51-57","source":"Crossref","is-referenced-by-count":14,"title":["Elimination of B-lineage leukemia and lymphoma cells from bone marrow grafts using anti-B4-blocked-ricin immunotoxin"],"prefix":"10.1007","volume":"15","author":[{"given":"Denis C.","family":"Roy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Perreault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"B\u00e9langer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Gyger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Le Houillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter A.","family":"Bl\u00e4ttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M.","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM198708203170801","volume":"317","author":"JH Kersey","year":"1987","unstructured":"Kersey JH, Weisdorf D, Nesbit ME, LeBien TW, Woods WG, McGlave PB, Kim T, Vallera DA, Goldman AI, Bostrom B, Hurd D, Ramsey NKC: Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 317:461?467, 1987","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJM199310283291802","volume":"329","author":"FM Uckun","year":"1993","unstructured":"Uckun FM, Kersey JH, Haake R, Weisdorf D, Nesbit ME, Ramsey NKC: Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N Engl J Med 329:1296?1301, 1993","journal-title":"N Engl J Med"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1056\/NEJM198608283150902","volume":"315","author":"Z Estrov","year":"1986","unstructured":"Estrov Z, Grunberger T, Dube ID, Wang YP, Freedman MH: Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission. N Engl J Med 315:538?542, 1986","journal-title":"N Engl J Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1182\/blood.V79.4.1074.bloodjournal7941074","volume":"79","author":"JG Sharp","year":"1992","unstructured":"Sharp JG, Joshi SS, Armitage JO, Bierman P, Coccia PF, Harrington DS, Kessinger A, Crouse DA, Mann SL, Weisenburger DD: Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by a culture technique. Blood 79:1074?1080, 1992","journal-title":"Blood"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1182\/blood.V79.4.1094.bloodjournal7941094","volume":"79","author":"FM Uckun","year":"1992","unstructured":"Uckun FM, Kersey JH, Haake R, Weisdorf D, Ramsay NKC: Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1\/CD24, BA-2\/CD9, and BA-3\/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging. Blood 79:1094?1104, 1992","journal-title":"Blood"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199008163230705","volume":"323","author":"M Yamada","year":"1990","unstructured":"Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, Rovera G: Minimal residual disease in childhood B-lineage lymphoblastic leukemia. N Engl J Med 323:448?455, 1990","journal-title":"N Engl J Med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood.V76.10.2072.2072","volume":"76","author":"OG Jonsson","year":"1990","unstructured":"Jonsson OG, Kitchens RL, Scott FC, Smith RG: Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes. Blood 76:2072?2079, 1990","journal-title":"Blood"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood.V73.7.1759.1759","volume":"73","author":"BY Ngan","year":"1989","unstructured":"Ngan BY, Nourse J, Cleary ML: Detection of chromosomal translocation 5(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 73:1759?1762, 1989","journal-title":"Blood"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1182\/blood.V78.12.3275.3275","volume":"78","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Woo SD, Blake K, Shu RS, Freeman G, Longtine JA, Pinkus GS, Nadler LM: All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275?3280, 1991","journal-title":"Blood"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0140-6736(93)92560-G","volume":"341","author":"MK Brenner","year":"1993","unstructured":"Brenner MK, Rill DR, Moen RC, Krance RA, Mirro J Jr, Anderson WF, Ihle JN: Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet 341:85?86, 1993","journal-title":"Lancet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood.V75.8.1606.1606","volume":"75","author":"NC Gorin","year":"1990","unstructured":"Gorin NC, Aegerter P, Auvert B, Meloni G, Goldstone AH, Burnett A, Carella A, Korbling M, Herve P, Maraninchi D, L\u00f6wenberg R, Verdonck LF, de Planque M, Hermans J, Helbig W, Porcellini A, Rizzoli V, Alesandrino EP, Franklin IM, Reiffers J, Colleselli P, Goldman JM: Autologous bone marrow transplantation for acute myelocytic leukemia in first remission: A european survey of the role of marrow purging. Blood 75:1606?1614, 1990","journal-title":"Blood"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/blood.V74.1.501.501","volume":"74","author":"SD Rowley","year":"1989","unstructured":"Rowley SD, Jones RJ, Piantadosi S, Braine HG, Colvin OM, Davis J, Saral R, Sharkis S, Wingard J, Yeager AM, Santos GW: Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemia. Blood 74:501?506, 1989","journal-title":"Blood"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199111283252201","volume":"325","author":"JG Gribben","year":"1991","unstructured":"Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo SD, Grossbard ML, Rabinowe SN, Coral F, Freeman GJ, Ritz J, Nadler LM: Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 325:1525?1533, 1991","journal-title":"N Engl J Med"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1021\/bi00227a011","volume":"30","author":"JM Lambert","year":"1991","unstructured":"Lambert JM, McIntyre G, Gauthier MN, Zullo D, Rao V, Steeves RM, Goldmacher VS, Bl\u00e4ttler WA: The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides. Biochemistry 30:3234?3247, 1991","journal-title":"Biochemistry"},{"key":"CR15","first-page":"6236","volume":"51","author":"JM Lambert","year":"1991","unstructured":"Lambert JM, Goldmacher VS, Collinson AR, Nadler LM, Bl\u00e4ttler WA: An immunotoxin prepared with blocked ricin: A natural plant toxin adapted for therapeutic use. Cancer Res 51:6236?6242, 1991","journal-title":"Cancer Res"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4612-4848-4_1","volume-title":"Leukocyte Typing II, Vol 2","author":"LM Nadler","year":"1986","unstructured":"Nadler LM: B cell\/Leukemia panel workshop: Summary and comments.In Leukocyte Typing II, Vol 2, EL Reinherz, FB Haynes, L Nadler, ID Bernstein (eds). New York, Springer-Verlag, 1986, pp 3?43"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0145-2126(84)90001-8","volume":"8","author":"JD Griffin","year":"1984","unstructured":"Griffin JD, Linch D, Sabbath K, Larcom P, Schlossman SF: A monoclonal antibody reactive with normal and leukemic progenitor cells. Leukemia Res 8:521?534, 1984","journal-title":"Leukemia Res"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0145-2126(90)90026-6","volume":"14","author":"DC Roy","year":"1990","unstructured":"Roy DC, Felix M, Cannady WG, Cannistra S, Ritz J: Comparative activities of rabbit complements of different ages using an in vitro marrow purging model. Leukemia Res 14:407?416, 1990","journal-title":"Leukemia Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.126.4.1614","volume":"126","author":"C Taswell","year":"1981","unstructured":"Taswell C: Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J Immunol 126:1614?1619, 1981","journal-title":"J Immunol"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jcp.1040830218","volume":"83","author":"NN Iscove","year":"1974","unstructured":"Iscove NN, Sciber F, Winterhalter KH: Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirements for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A. J Cell Physiol 83:309?320, 1974","journal-title":"J Cell Physiol"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF01035488","volume":"41","author":"HA Messner","year":"1980","unstructured":"Messner HA, Fauser AA: Culture studies of human pluripotent hemopoietic progenitors. Blut 41:327?333, 1980","journal-title":"Blut"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1200\/JCO.1993.11.4.726","volume":"11","author":"ML Grossbard","year":"1993","unstructured":"Grossbard ML, Lambert JM, Goldmacher VS, Spector NL, Kinsella J, Eliseo L, Coral F, Taylor JA, Bl\u00e4ttler WA, Epstein CL, Nadler LM: Anti-B4-blocked-ricin: A phase I trial of 7-day continuous infusion in patients with B-cell neoplasms. J Clin Oncol 11:726?737, 1993","journal-title":"J Clin Oncol"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1182\/blood.V81.9.2263.2263","volume":"81","author":"ML Grossbard","year":"1993","unstructured":"Grossbard ML, Gribben JG, Freedman AS, Lambert JM, Kinsella J, Rabinowe SN, Eliseo L, Taylor JA, Bl\u00e4ttler WA, Epstein CL, Nadler LM: Adjuvant immunotoxin therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with B-cell non-Hodgkin's lymphoma. Blood 81:2263?2271, 1993","journal-title":"Blood"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1126\/science.2047874","volume":"252","author":"TA Waldman","year":"1991","unstructured":"Waldman TA: Monoclonal antibodies in diagnosis and therapy. Science 252:1657?1662, 1991","journal-title":"Science"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1182\/blood.V77.11.2404.2404","volume":"77","author":"DC Roy","year":"1991","unstructured":"Roy DC, Griffin JD, Belvin M, Bl\u00e4ttler WA, Lambert JM, Ritz J: Anti-MY9-blocked-ricin: An immunotoxin for selective targeting of acute myeloid leukemia cells. Blood 77:2404?2412, 1991","journal-title":"Blood"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"436S","DOI":"10.1378\/chest.103.4_Supplement.436S","volume":"103","author":"TJ Lynch Jr","year":"1993","unstructured":"Lynch TJ Jr: Immunotoxin therapy of small cell lung cancer N901-blocked ricin for relapsed small cell lung cancer. Chest 103:436S-439S, 1993","journal-title":"Chest"},{"key":"CR27","first-page":"231","volume":"33","author":"I Novak-Hofer","year":"1992","unstructured":"Novak-Hofer I, Amstutz HP, Haldemann A, Blaser K, Morgenthaler JJ, Blauenstein P, Schubiger PA: Radioimmunolocalization of neuroblastoma xenografts with chimeric antibody chCE7. J Nucl Med 33:231?236, 1992","journal-title":"J Nucl Med"},{"key":"CR28","first-page":"243","volume":"12","author":"RJ Soiffer","year":"1993","unstructured":"Soiffer RJ, Roy DC, Gonin R, Murray C, Anderson KC, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Pesek K, Mauch P, Nadler LM, Ritz J: Monoclonal antibody-purged autologous bone marrow transplantation in adults with acute lymphoblastic leukemia at high risk of relapse. Bone Marrow Transplant 12:243?251, 1993","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"CR29","first-page":"81a","volume":"82","author":"DC Roy","year":"1993","unstructured":"Roy DC, Gyger M, B\u00e9langer R, Perreault C, Bonny Y, Soiffer R, Esseltine D, Ritz J: Engraftment following autologous bone marrow transplantation with Anti-B4-bR depleted marrow for patients with B-cell malignancies. Blood 82 (Suppl 1):81a, 1993","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01489490.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01489490\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01489490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:12:35Z","timestamp":1683069155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01489490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1995,1]]}},"alternative-id":["BF01489490"],"URL":"https:\/\/doi.org\/10.1007\/bf01489490","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,1]]}}}